Nivolumab-induced systemic vasculitis

JAAD Case Rep. 2018 Jun 23;4(6):606-608. doi: 10.1016/j.jdcr.2018.03.013. eCollection 2018 Jul.
No abstract available

Keywords: Ab, antibody; CT, computerized tomography; CTLA-4, cytotoxic T-lymphocyte–associated protein 4; PD-1, programmed cell death-1 receptor; drug reaction; irAEs, immune-related adverse events; leukocytoclastic vasculitis; programmed cell death-1 receptor inhibition; small bowel vasculitis.

Publication types

  • Case Reports